Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.
Also called NCT06410352
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 220 participants
- Sponsor
- University Medical Center, Kazakhstan
- Registry
-
NCT06410352
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Kazakhstan
- Registry status
- Recruiting
Technical summary
Registry record NCT06410352. Non-randomized; no masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2025-09-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
- Condition
- Metabolic Syndrome
- Intervention (Drug)
- Semaglutide, Empagliflozin
- Intervention (Procedure)
- Minigastric bypass
- Intervention (Dietary supplement)
- Analimentary detoxication
- Intervention (Behavioral)
- Ramadan fast's weight loss
- Lead sponsor
- University Medical Center, Kazakhstan
- Collaborator
- Nazarbayev University School of Medicine
- Collaborator
- Nazarbayev University
- Collaborator
- Astana Medical University
- Collaborator
- Public Association "Eurasian Society of Personalized Medicine"
- Collaborator
- Ministry of Science and Higher Education of the Republic of Kazakhstan
Record details
- Record id
cardio:ct-nct06410352- Content hash
63ce2f658eeb8b7f819030cea4416d73523b85a064c9643df60246c6db45aab5